Literature DB >> 8302015

Subcellular localization of peripheral benzodiazepine receptors on human leukocytes.

D Cahard1, X Canat, P Carayon, C Roque, P Casellas, G Le Fur.   

Abstract

BACKGROUND: The peripheral-type benzodiazepine receptor (PBR) was initially identified in many peripheral tissues and in some blood cells. Drugs that bind with high affinity to PBRs have previously been described as having immunomodulating properties. The number of PBRs varies according to the cell population considered. The aim of this study was to study the localization of PBRs in two human leukocyte populations, T4-lymphocytes, and monocytes. EXPERIMENTAL
DESIGN: Both cell populations were purified by negative immunoselection in order to keep only the physiologically accessible sites on the viable cells. Mitochondria were quantified by electron microscopy and flow cytometric analysis. Subcellular localization was then studied after PBR photoaffinity labeling using electron microscopic ultrastructural autoradiography.
RESULTS: We have shown that monocytes contain twice as many mitochondria as lymphocytes. We have also shown that the global labeling of monocytes by ultrastructural autoradiography is actually higher than that of lymphocytes and the labeling of monocyte mitochondria is higher than that of lymphocyte mitochondria. In addition, the distribution of subcellular labeling indicates that there are different populations of mitochondria in one cell, i.e., labeled and unlabeled, and that the percentage of labeled mitochondria is greater in monocytes. These results are consistent with those obtained in previous binding studies. Finally, over 50% of receptors are localized in cell compartments devoid of visible mitochondria.
CONCLUSIONS: The subcellular distribution of the PBR shows that this receptor could have other physiologic functions towards immune cells than a function associated with mitochondria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302015

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

Review 1.  The peripheral benzodiazepine receptors: a review.

Authors:  A Beurdeley-Thomas; L Miccoli; S Oudard; B Dutrillaux; M F Poupon
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Pro and antioxidant responses to repeated administration of diazepam in rat brain.

Authors:  S Musavi; P Kakkar
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

3.  Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.

Authors:  DeLisa Fairweather; Michael J Coronado; Amanda E Garton; Jennifer L Dziedzic; Adriana Bucek; Leslie T Cooper; Jessica E Brandt; Fatima S Alikhan; Haofan Wang; Christopher J Endres; Judy Choi; Martin G Pomper; Tomás R Guilarte
Journal:  J Cardiovasc Transl Res       Date:  2014-01-09       Impact factor: 4.132

4.  Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain.

Authors:  Sarah Musavi; Poonam Kakkar
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 5.  Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope?

Authors:  Pooneh Salari; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

6.  Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro.

Authors:  Sergey V Kalashnikov; Elena A Kalashnikova; Svetlana N Kokarovtseva
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

7.  Specific regulation of low-abundance transcript variants encoding human Acyl-CoA binding protein (ACBP) isoforms.

Authors:  Inke Nitz; Marie-Luise Kruse; Maja Klapper; Frank Döring
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

8.  The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas.

Authors:  Shigetoshi Takaya; Kazuo Hashikawa; Federico E Turkheimer; Nicholas Mottram; Manuel Deprez; Koichi Ishizu; Hidekazu Kawashima; Haruhiko Akiyama; Hidenao Fukuyama; Richard B Banati; Federico Roncaroli
Journal:  J Neurooncol       Date:  2007-05-23       Impact factor: 4.130

Review 9.  Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issue.

Authors:  Manuel J Rodríguez; Margot Martínez-Moreno; Francisco J Ortega; Nicole Mahy
Journal:  Oxid Med Cell Longev       Date:  2013-06-16       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.